1. Home
  2. WLDS vs CLGN Comparison

WLDS vs CLGN Comparison

Compare WLDS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$1.44

Market Cap

19.7M

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$1.36

Market Cap

23.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
CLGN
Founded
2014
2004
Country
Israel
Israel
Employees
N/A
N/A
Industry
Computer Communications Equipment
Industrial Specialties
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
23.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
WLDS
CLGN
Price
$1.44
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.50
AVG Volume (30 Days)
239.4K
25.0K
Earning Date
12-10-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,000.00
$2,475,000.00
Revenue This Year
N/A
$1,617.28
Revenue Next Year
N/A
$83.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
280.77
52 Week Low
$1.00
$1.31
52 Week High
$11.40
$4.98

Technical Indicators

Market Signals
Indicator
WLDS
CLGN
Relative Strength Index (RSI) 31.38 24.42
Support Level $1.83 $1.77
Resistance Level $1.60 $1.93
Average True Range (ATR) 0.12 0.15
MACD -0.00 -0.06
Stochastic Oscillator 5.38 9.44

Price Performance

Historical Comparison
WLDS
CLGN

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: